Standard Biotools reported $555.75M in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.36B 241M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 2.44B 67M Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
Illumina USD 3.14B 307M Sep/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Nikon Corporation JPY 593.05B 314M Sep/2026
Pacific Biosciences Of California USD -61.38M 28.17M Sep/2026
Revvity USD 7.23B 46.02M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sony JPY 8.55T 181.11B Sep/2026
Standard Biotools USD 555.75M 15.78M Sep/2026
Thermo Fisher Scientific USD 54.76B 2.08B Sep/2026
Waters USD 15.2B 97M Jun/2026